Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Moodys
Dow
McKinsey
Covington
Baxter
Medtronic
Julphar
Healthtrust

Generated: July 15, 2018

DrugPatentWatch Database Preview

Saralasin acetate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for saralasin acetate and what is the scope of saralasin acetate patent protection?

Saralasin acetate
is the generic ingredient in one branded drug marketed by Procter And Gamble and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for saralasin acetate
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 18
Patent Applications: 1,401
DailyMed Link:saralasin acetate at DailyMed
Medical Subject Heading (MeSH) Categories for saralasin acetate
Synonyms for saralasin acetate
(1-(N-Methylglycin) 5-L-valin, 8-L-alanin)angiotensin II
(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-(diaminomethylideneamino)-2-[[2-(methylamino)acetyl]amino]pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylbutanoyl]amino]-3-(1H-
(S)-2-((S)-1-((S)-2-((S)-2-((S)-2-((S)-2-((S)-5-(diaminomethyleneamino)-2-(2-(methylamino)acetamido)pentanamido)-3-methylbutanamido)-3-(4-hydroxyphenyl)propanamido)-3-methylbutanamido)-3-(1H-imidazol-5-yl)propanoyl)pyrrolidin
(Sar1,Val5,Ala8)-Angiotensin II
[Sar1-Arg2-Val3-Tyr4-Val5-His6-Pro7-Ala8]
[Sar1, Val5, Ala8]-Angiotensin II acetate salt hydrate
[Sar1, Val5, Ala8]-Angiotensin II acetate salt hydrate, >=97% (HPLC), powder
34273-10-4
34273-10-4 (Parent)
39698-78-7
39698-78-7 (acetate, hydrated)
AC1O44IX
ACETIC ACID SARALASIN HYDRATE
AKOS024456428
AM023433
Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine-
aralasin
BDBM50009338
C-23576
CAS-34273-10-4
CHEBI:135894
CHEMBL1200670
CHEMBL938
D04126
DSSTox_CID_26549
DSSTox_GSID_46549
DSSTox_RID_81710
DTXSID2046549
FO21Z580M4
FT-0630581
H2AFV2HE66
N-(1-(N-(N-(N-(N-(N2-(N-methylglycly)-L-arginyl)-L-valyl)-L-tyrosyl)-L-valyl)-L-histidyl)-L-prolyl)-L-alanine
NCGC00166135-01
NCGC00167316-01
P-113
Sar-Arg-Val-Tyr-Val-His-Pro-Ala (sarlasin)
Saralasin
Saralasin [INN:BAN]
Saralasin acetate (USAN)
Saralasin acetate [USAN]
Saralasin acetate hydrate
Saralasina
Saralasina [INN-Spanish]
Saralasine
Saralasine [INN-French]
Saralasinum
Saralasinum [INN-Latin]
Sarenin
Sarenin (TN)
SCHEMBL2200145
SCHEMBL23
Tox21_112332
UNII-FO21Z580M4
UNII-H2AFV2HE66
ZINC169289386

US Patents and Regulatory Information for saralasin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Procter And Gamble SARENIN saralasin acetate INJECTABLE;INJECTION 018009-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for saralasin acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Procter And Gamble SARENIN saralasin acetate INJECTABLE;INJECTION 018009-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Procter And Gamble SARENIN saralasin acetate INJECTABLE;INJECTION 018009-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Citi
Cerilliant
Harvard Business School
Moodys
Boehringer Ingelheim
Queensland Health
Mallinckrodt
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.